Assignee
POSEIDA THERAPEUTICS INC
US·22 granted patents·44 pending applications·107 citations·filing 2013–2025
Top patents by PatentIndex Score
66 records- 0196US10513686B2Modified stem cell memory T cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·12 cites·30 claims
- 0295US10329543B2Modified stem cell memory T cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2017·Granted Jun 25, 2019·14 cites·28 claims
- 0395US10131885B2Hyperactive piggybac transposasesPOSEIDA THERAPEUTICS INC·Filed 2017·Granted Nov 20, 2018·11 cites·17 claims
- 0494US10287559B2Hyperactive PiggyBac transposasesPOSEIDA THERAPEUTICS INC·Filed 2016·Granted May 14, 2019·7 cites·17 claims
- 0593US11718656B2Inducible caspases and methods for usePOSEIDA THERAPEUTICS INC·Filed 2022·Granted Aug 8, 2023·1 cites·10 claims
- 0692US10415024B2Site-specific enzymes and methods of usePOSEIDA THERAPEUTICS INC·Filed 2013·Granted Sep 17, 2019·25 cites·8 claims
- 0792US9546382B2Hyperactive piggybac transposasesPOSEIDA THERAPEUTICS INC·Filed 2013·Granted Jan 17, 2017·12 cites·24 claims
- 0890US10456452B2Compositions and methods for improved encapsulation of functional proteins in polymeric vesiclesPOSEIDA THERAPEUTICS INC·Filed 2016·Granted Oct 29, 2019·15 cites·11 claims
- 0989US10415016B2Modified stem cell memory T cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2018·Granted Sep 17, 2019·3 cites·22 claims
- 1086US12358966B2Inducible caspases and methods for usePOSEIDA THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·0 cites·7 claims
- 1186US11802269B2Superpiggybac transposase compositionsPOSEIDA THERAPEUTICS INC·Filed 2019·Granted Oct 31, 2023·1 cites·5 claims
- 1286US11377480B2Inducible caspases and methods for usePOSEIDA THERAPEUTICS INC·Filed 2017·Granted Jul 5, 2022·2 cites·1 claims
- 1381US11485959B2Hyperactive piggybac transposasesPOSEIDA THERAPEUTICS INC·Filed 2019·Granted Nov 1, 2022·1 cites·16 claims
- 1480US12415844B2BCMA specific VCAR compositions and methods for usePOSEIDA THERAPEUTICS INC·Filed 2018·Granted Sep 16, 2025·1 cites·79 claims
- 1580US2026001929A1Inducible caspases and methods for usePOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1678US10844361B2Site-specific enzymes and methods of usePOSEIDA THERAPEUTICS INC·Filed 2019·Granted Nov 24, 2020·1 cites·17 claims
- 1778US2024150734A1Hyperactive piggybac transposasesPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1877US10131634B2Method of treating painPOSEIDA THERAPEUTICS INC·Filed 2014·Granted Nov 20, 2018·1 cites·2 claims
- 1976US2024318136A1Modified stem cell memory t cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2074US2024084251A1Modified stem cell memory t cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2171US2024226153A9Compositions and methods for selective elimination and replacement of hematopoietic stem cellsPOSEIDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2265US2026071213A1Compositions targeting hbg1 and hbg2 and methods of use thereofPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2365US2020338361A1Compositions and methods for inducing nanoparticle-mediated microvascular embolization for tumorsPOSEIDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2464US2025171809A1Genetically modified cells and methods of use thereofPOSEIDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2563US2021062170A1Site-specific enzymes and methods of usePOSEIDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2663US2026021207A1Super minimal inverted terminal repeat (itr) sequences and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2763US2026022354A1Transposases and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2863US2026022353A1Transposase polynucleotides and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2963US2026055383A1Transposases and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3063US2023257737A1Compositions and methods for directing proteins to specific loci in the genomePOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3163US2019119636A1Modified stem cell memory t cells, methods of making and methods of using samePOSEIDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3263US2026085332A1Chimeric transposases and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3362US11744861B2Compositions and methods for selective elimination and replacement of hematopoietic stem cellsPOSEIDA THERAPEUTICS INC·Filed 2018·Granted Sep 5, 2023·0 cites·19 claims
- 3462US10987409B2Compositions and methods for improved encapsulation of functional proteins in polymeric vesiclesPOSEIDA THERAPEUTICS INC·Filed 2019·Granted Apr 27, 2021·0 cites·10 claims
- 3562US2024401085A1Transposon compositions and methods of use thereofPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3662US2020138716A1Compositions and methods for inducing nanoparticle-mediated microvascular embolization of tumorsPOSEIDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3762US2025099383A1Compositions and methods for delivery of nucleic acidsPOSEIDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3861US2024392262A1Transposase and uses thereofPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3960US2026069539A1Lipidoid compounds and related compositions and usesPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4060US2026083860A1Compositions and methods for genome editingPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4159US2024060090A1Genetically modified induced pluripotent stem cells and methods of use thereofPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4258US2026069714A1Lipidoid compounds and related compositions and usesPOSEIDA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4357US2024182921A1Compositions and methods for the treatment of hemophiliaPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4456US2019135759A1Method of treating painPOSEIDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4555US2022042038A1Nanotransposon compositions and methods of usePOSEIDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4655US2020001110A1Compositions and methods for inducing nanoparticle-mediated microvascular embolization for tumorsPOSEIDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4755US2019233843A1Transposon system and methods of usePOSEIDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4855US2026042732A1Sulfur-containing Compounds and Compositions Thereof for Delivery of Nucleic AcidsPOSEIDA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4954US2023079955A1Anti-muc1 compositions and methods of usePOSEIDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 5053US2024189446A1Compositions and methods for delivery of nucleic acidsPOSEIDA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →